By contrast, a clinicopathologically conflicting role for podoplanin, namely as a favorable prognostic factor for patients with lung/cervical squamous cell carcinoma (SCC), has recently been reported. The gene discussed is PDPN; the disease is cervical squamous cell carcinoma.